Vascular leakage in non-small cell lung cancer is associated with immune evasion and poor response to immunotherapy
Cancer Letters · 2026
DOI: 10.1016/j.canlet.2026.218728 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von Emmanuel Nwadozi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Beijer Gene and Neuro Laboratory and Science for Life Laborato…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Immunotherapy, Tumor Escape. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Sjöberg Foundation, Swedish Cancer Society.
Abstract (Originalsprache)
Leaky blood vessels are a hallmark of solid tumors. However, the molecular mechanisms and clinical implications of vascular leakage in human cancer remain unexplored. Here, we identified fibrinopeptide-A (FpA) as a robust in-situ marker of vascular leakage, analyzing diagnostic specimens from two non-small cell lung cancer (NSCLC) cohorts (N = 327 and N = 200). Mechanistically, FpA+ staining localized to discrete stromal niches characterized by increased endothelial VEGF receptor-2 phosphorylation, elevated VEGFA production by tumor cells and loss of the endothelial tyrosine phosphatase PTPRB. Immune profiling revealed reduced density of mature dendritic cells and granzyme B-expressing cytotoxic T cells in tumors with high-leakage. This leakage-associated immunosuppression was linked to the presence of tertiary lymphoid structures (TLS) in lung adenocarcinoma (LUAD). However, compared to low-leakage, TLS in high-leakage tumors were enriched in regulatory T cells and conferred no survival advantage. Patients with high vascular leakage exhibited a reduced overall survival. Moreover, in a separate immunotherapy cohort (N = 64), high-leakage was associated with poor response to anti-PD-1/PD-L1 treatment. This study establishes vascular leakage as an important prognostic factor in NSCLC, and provides mechanistic understanding and a methodological framework to stratify NSCLC patients with regard to responsiveness to immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Beijer Gene and Neuro Laboratory and Science for Life Laboratories, Uppsala University, Uppsala, Sweden. Electronic address: emmanue…
- Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
- Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Beijer Gene and Neuro Laboratory and Science for Life Laboratories, Uppsala University, Uppsala, Sweden.
- Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
- Histology, Research Center Borstel - Leibniz Lung Center, Germany & Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Borstel, Germany.
- Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Centre for Research and Development, Uppsala University, Uppsala, Region Gävleborg, Sweden.
Förderung
- Swedish Research Council
- Sjöberg Foundation
- Swedish Cancer Society
- Knut and Alice Wallenberg Foundation
Zitieren
APA
Nwadozi, E., Strell, C., Nordling, S., Lindberg, A., Backman, M., Cosmen, P. D., Marwitz, S., Goldmann, T., Isaksson, J., Botling, J., Brunnström, H., Lindskog, C., Micke, P., & Claesson-Welsh, L. (2026). Vascular leakage in non-small cell lung cancer is associated with immune evasion and poor response to immunotherapy. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218728
Vancouver
Nwadozi E, Strell C, Nordling S, Lindberg A, Backman M, Cosmen PD, et al. Vascular leakage in non-small cell lung cancer is associated with immune evasion and poor response to immunotherapy. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218728
BibTeX
@article{Nwadozi2026,
author = {Nwadozi, Emmanuel and Strell, Carina and Nordling, Sofia and Lindberg, Amanda and Backman, Max and Cosmen, Patricia Daller and Marwitz, Sebastian and Goldmann, Torsten and Isaksson, Johan and Botling, Johan and Brunnström, Hans and Lindskog, Cecilia and Micke, Patrick and Claesson-Welsh, Lena},
title = {Vascular leakage in non-small cell lung cancer is associated with immune evasion and poor response to immunotherapy},
journal = {Cancer Letters},
year = {2026},
doi = {10.1016/j.canlet.2026.218728}
}
EUVIMED